| For: | Han L, Zhang HW, Xie JX, Zhang Q, Wang HY, Cao GW. A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus. World J Gastroenterol 2011; 17(38): 4321-4333 [PMID: 22090789 DOI: 10.3748/wjg.v17.i38.4321] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i38/4321.htm |
| Number | Citing Articles |
| 1 |
. 2015; doi: 10.70675/1861201cz8d71z4b78za6e9za3249f40396a
|
| 2 |
J C Dunkelberg, E M F Berkley, K W Thiel, K K Leslie. Hepatitis B and C in pregnancy: a review and recommendations for care. Journal of Perinatology 2014; 34(12) doi: 10.1038/jp.2014.167
|
| 3 |
Vitaliy A. Kaptilnyy, Diana Yu. Reyshtat, Manana V. Berishvili, Mariya N. Zholobova. Hepatitis B and C during pregnancy. V.F.Snegirev Archives of Obstetrics and Gynecology 2021; 8(3) doi: 10.17816/2313-8726-2021-8-3-121-131
|
| 4 |
Jun-Ze Chen, Zuo-Wei Liao, Fei-Long Huang, Ru-Kui Su, Wen-Bo Wang, Xue-Yuan Cheng, Jie-Qing Chen, Jia-Qi Liu, Zhong Huang. Efficacy and safety of tenofovir disoproxil fumarate in preventing vertical transmission of hepatitis B in pregnancies with high viral load. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-04479-x
|
| 5 |
Yi Shen, Yulong Jia, Jie Zhou, Juling Ji, Pengcheng Xun. Bayesian Network Meta-Analysis for Assessing Adverse Effects of Anti-hepatitis B Drugs. Clinical Drug Investigation 2019; 39(9) doi: 10.1007/s40261-019-00802-8
|
| 6 |
. 2021; doi: 10.70675/33a3c98bzd4b0z4b34z8620z8b32cf1e0d1b
|
| 7 |
|
| 8 |
I.D. Ramsay, J.M. Lestner, C.I.S. Barker. A worldwide yearly survey of new data in adverse drug reactions and interactions. Side Effects of Drugs Annual 2014; 35 doi: 10.1016/B978-0-444-62635-6.00029-2
|
| 9 |
Sumona Saha, Nancy Reau. Yamada' s Textbook of Gastroenterology. 2015; doi: 10.1002/9781118512074.ch46
|
| 10 |
Noele P. Nelson, Denise J. Jamieson, Trudy V. Murphy. Prevention of Perinatal Hepatitis B Virus Transmission. Journal of the Pediatric Infectious Diseases Society 2014; 3(suppl_1) doi: 10.1093/jpids/piu064
|
| 11 |
Meagan Gray, Don C. Rockey. A Spotty Liver of Pregnancy. Journal of Investigative Medicine High Impact Case Reports 2014; 2(3) doi: 10.1177/2324709614551558
|
| 12 |
KENDRA R. SYLVESTER-ARMSTRONG, PATRICK DUFF. Evidence for Use of Tenofovir in Pregnancy to Prevent Perinatal Transmission of Hepatitis B Infection. Clinical Obstetrics & Gynecology 2019; 62(4) doi: 10.1097/GRF.0000000000000438
|
| 13 |
K.W. Cheung, M.T.Y. Seto, S.F. Wong. Towards complete eradication of hepatitis B infection from perinatal transmission: review of the mechanisms of in utero infection and the use of antiviral treatment during pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology 2013; 169(1) doi: 10.1016/j.ejogrb.2013.02.001
|
| 14 |
. 2015; doi: 10.70675/f7790642za2fez4cb0zbc9czf367e77be492
|
| 15 |
Zhenhua Li, Xuefei Duan, Yuhong Hu, Mingfang Zhou, Min Liu, Kai Kang, Haodong Cai, Wei Yi, Dong Fu, Xuesong Gao, Jean-Pierre Molès. Efficacy and Safety of Lamivudine or Telbivudine in Preventing Mother‐to‐Child Transmission of Hepatitis B Virus: A Real‐World Study. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/1374276
|
| 16 |
Cheuk Y.W. Tong, Carol Robson, Yin Wu, Rozanna Issa, Timothy Watts, Mark Wilkinson, Terry Wong, Ann Lorek. Post-vaccination serological test results of infants at risk of perinatal transmission of hepatitis B using an intensified follow-up programme in a London centre. Vaccine 2013; 31(31) doi: 10.1016/j.vaccine.2013.04.083
|
| 17 |
Shishu Zhu, Yi Dong, Limin Wang, Weiwei Liu, Pan Zhao. Early initiation of antiviral therapy contributes to a rapid and significant loss of serum HBsAg in infantile-onset hepatitis B. Journal of Hepatology 2019; 71(5) doi: 10.1016/j.jhep.2019.06.009
|
| 18 |
Zixiong Li, Zhenyu Xie, Hongxia Ni, Qi Zhang, Wei Lu, Jianhua Yin, Wenbin Liu, Yibo Ding, Yan Zhao, Yibing Zhu, Rui Pu, Hongwei Zhang, Hongjun Dong, Yifei Fu, Qiao Sun, Guozhang Xu, Guangwen Cao. Mother-to-child transmission of hepatitis B virus: Evolution of hepatocellular carcinoma-related viral mutations in the post-immunization era. Journal of Clinical Virology 2014; 61(1) doi: 10.1016/j.jcv.2014.06.010
|
| 19 |
Teerha Piratvisuth. Optimal management of HBV infection during pregnancy. Liver International 2013; 33(s1) doi: 10.1111/liv.12060
|
| 20 |
Jae Hoon Kim, Ju Seung Kim, Jong Joon Lee, Jung Ho Kim, Suk Young Kim, Young Kul Jung, Oh Sang Kwon, Yun Soo Kim, Duck Joo Choi, Ju Hyun Kim. Survey of perinatal hepatitis B virus transmission after Korean National Prevention Program in a tertiary hospital. The Korean Journal of Internal Medicine 2014; 29(3) doi: 10.3904/kjim.2014.29.3.307
|
| 21 |
Evangelos Cholongitas, Konstantinos Tziomalos, Chrysoula Pipili. Management of patients with hepatitis B in special populations. World Journal of Gastroenterology 2015; 21(6): 1738-1748 doi: 10.3748/wjg.v21.i6.1738
|
| 22 |
|
| 23 |
Anais Vallet-Pichard, Stanislas Pol. Hepatitis B virus treatment beyond the guidelines: special populations and consideration of treatment withdrawal. Therapeutic Advances in Gastroenterology 2014; 7(4) doi: 10.1177/1756283X14524614
|
| 24 |
Harry L.A. Janssen, Jurrien Reijnders, Milan Sonneveld. Zakim and Boyer's Hepatology. 2018; doi: 10.1016/B978-0-323-37591-7.00033-1
|
| 25 |
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection. Journal of Hepatology 2012; 57(1) doi: 10.1016/j.jhep.2012.02.010
|
| 26 |
Stacy Menees, Grace L. Su. Yamada's Textbook of Gastroenterology. 2022; doi: 10.1002/9781119600206.ch40
|
| 27 |
Erin Kelly, Marion G. Peters. Management of HBV in Pregnancy. Current Hepatology Reports 2015; 14(3) doi: 10.1007/s11901-015-0266-6
|
| 28 |
Marianna G. Mavilia, George Y. Wu. Mechanisms and Prevention of Vertical Transmission in Chronic Viral Hepatitis. Journal of Clinical and Translational Hepatology 2017; 5(2) doi: 10.14218/JCTH.2016.00067
|
| 29 |
Ireen Akhter, Zinia Jafrin Munni, Tanvir Adnan. Incidence of hepatitis B virus infection and associated risk factors among pregnant women in SSMC, Mitford Hospital. International Journal of Reproduction, Contraception, Obstetrics and Gynecology 2026; 15(3) doi: 10.18203/2320-1770.ijrcog20260538
|
| 30 |
Philippe Sogni. Grossesse et hépatites virales B et C. La Presse Médicale 2015; 44(6) doi: 10.1016/j.lpm.2015.04.018
|
| 31 |
Kali Zhou, Norah Terrault. Management of hepatitis B in special populations. Best Practice & Research Clinical Gastroenterology 2017; 31(3) doi: 10.1016/j.bpg.2017.06.002
|
| 32 |
|
| 33 |
Andrew J. Prendergast, Paul Klenerman, Philip J. R. Goulder. The impact of differential antiviral immunity in children and adults. Nature Reviews Immunology 2012; 12(9) doi: 10.1038/nri3277
|
| 34 |
Hua Xu, Teng Zeng, Jun-Ying Liu, Yu Lei, Shan Zhong, Yun-Jian Sheng, Zhi Zhou, Hong Ren. Measures to Reduce Mother-to-Child Transmission of Hepatitis B Virus in China: A Meta-Analysis. Digestive Diseases and Sciences 2014; 59(2) doi: 10.1007/s10620-013-2918-0
|
| 35 |
Monika Sarkar, Norah A. Terrault. Ending vertical transmission of hepatitis B: The third trimester intervention. Hepatology 2014; 60(2) doi: 10.1002/hep.27145
|
| 36 |
Peng Zhao, Xueqian Qian, Chang Su, Xiaofu Yang, Xiaoxia Bai. Lamivudine vs placebo or no treatment in preventing the transmission of hepatitis B virus during pregnancy: a systematic review and meta-analysis. Transactions of The Royal Society of Tropical Medicine and Hygiene 2019; doi: 10.1093/trstmh/trz078
|
| 37 |
Yuliia Mudra. THE TACTICS OF ANTIVIRAL THERAPY FOR CHRONIC VIRAL HEPATITIS B IN PREGNANT WOMEN. Technology transfer: innovative solutions in medicine 2020; 4 doi: 10.21303/2585-663.2020.001478
|
| 38 |
Huihui Zeng, Haodong Cai, Ying Wang, Ying Shen. Growth and development of children prenatally exposed to telbivudine administered for the treatment of chronic hepatitis B in their mothers. International Journal of Infectious Diseases 2015; 33 doi: 10.1016/j.ijid.2014.09.002
|
| 39 |
Wolfram H. Gerlich. Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives. Medical Microbiology and Immunology 2015; 204(1) doi: 10.1007/s00430-014-0373-y
|
| 40 |
Daneshmand Dana, Nokhodian Zary, Adibi Peyman, Ataei Behrooz, A. Aghakhani, M. Banifazl, A. Ramezani. Risk Prison and Hepatitis B Virus Infection among Inmates with History of Drug Injection in Isfahan, Iran. The Scientific World Journal 2013; 2013(1) doi: 10.1155/2013/735761
|
| 41 |
Wolfram H. Gerlich. Reduction of Infectivity in Chronic Hepatitis B Virus Carriers among Healthcare Providers and Pregnant Women by Antiviral Therapy. Intervirology 2014; 57(3-4) doi: 10.1159/000360949
|
| 42 |
Yao Hu, Hui Yu. Prevention strategies of mother‐to‐child transmission of hepatitis B virus (HBV) infection. Pediatric Investigation 2020; 4(2) doi: 10.1002/ped4.12205
|
| 43 |
Y. Bacq, C. Gaudy-Graffin, S. Marchand. Prévention de la transmission materno-infantile du virus de l’hépatite B. Archives de Pédiatrie 2015; 22(4) doi: 10.1016/j.arcped.2014.12.017
|
| 44 |
Zixiong Li, Xiaomei Hou, Guangwen Cao. Is mother-to-infant transmission the most important factor for persistent HBV infection?. Emerging Microbes & Infections 2015; 4(1) doi: 10.1038/emi.2015.30
|
| 45 |
Natalie H. Bzowej. Optimal Management of the Hepatitis B Patient Who Desires Pregnancy or Is Pregnant. Current Hepatitis Reports 2012; 11(2) doi: 10.1007/s11901-012-0130-x
|
| 46 |
Ashish Kumar. Hepatitis B virus infection and pregnancy: a practical approach. Indian Journal of Gastroenterology 2012; 31(2) doi: 10.1007/s12664-012-0174-4
|
| 47 |
G. Ducarme, M. Schnee, V. Dochez. Hepatitis y embarazo. EMC - Ginecología-Obstetricia 2016; 52(2) doi: 10.1016/S1283-081X(16)77884-2
|
| 48 |
Semvua B. Kilonzo, Daniel W. Gunda, Bonaventura C. T. Mpondo, Fatma A. Bakshi, Hyasinta Jaka. Hepatitis B Virus Infection in Tanzania: Current Status and Challenges. Journal of Tropical Medicine 2018; 2018 doi: 10.1155/2018/4239646
|
| 49 |
Naichaya Chamroonkul, Teerha Piratvisuth. Hepatitis B During Pregnancy in Endemic Areas: Screening, Treatment, and Prevention of Mother-to-Child Transmission. Pediatric Drugs 2017; 19(3) doi: 10.1007/s40272-017-0229-1
|
| 50 |
Heather Patton, Tram T. Tran. Management of hepatitis B during pregnancy. Nature Reviews Gastroenterology & Hepatology 2014; 11(7) doi: 10.1038/nrgastro.2014.30
|
| 51 |
Sarah C. Rogan, Richard H. Beigi. Treatment of Viral Infections During Pregnancy. Clinics in Perinatology 2019; 46(2) doi: 10.1016/j.clp.2019.02.009
|
| 52 |
Flavia Matovu Kiweewa, Camlin Tierney, Kevin Butler, Marion G. Peters, Tichaona Vhembo, Dhayendre Moodley, Vani Govender, Neaka Mohtashemi, Hannah Ship, Philippa Musoke, Dingase Dula, Kathy George, Nahida Chakhtoura, Mary G. Fowler, Judith S. Currier, Debika Bhattacharya. Brief Report: Impact of Antiretroviral Regimen on Pregnancy and Infant Outcomes in Women With HIV/ HBV Coinfection. JAIDS Journal of Acquired Immune Deficiency Syndromes 2022; 91(1) doi: 10.1097/QAI.0000000000003022
|
| 53 |
MARGUERITE L. BARTHOLOMEW, MEN-JEAN LEE. Management of Hepatitis B Infection in Pregnancy. Clinical Obstetrics & Gynecology 2018; 61(1) doi: 10.1097/GRF.0000000000000331
|
| 54 |
Jiahui Song, Fan Yang, Shuo Wang, Sakinatou Tikande, Yang Deng, Weina Tang, Guangwen Cao. Efficacy and safety of antiviral treatment on blocking the mother‐to‐child transmission of hepatitis B virus: A meta‐analysis. Journal of Viral Hepatitis 2019; 26(3) doi: 10.1111/jvh.13036
|
| 55 |
Cynthuja Thilakanathan, Gabrielle Wark, Michael Maley, Scott Davison, Joseph Lawler, Aimei Lee, Nicholas Shackel, Vi Nguyen, Kathy Jackson, Anne Glass, Stephen A. Locarnini, Miriam T. Levy. Mother‐to‐child transmission of hepatitis B: Examining viral cut‐offs, maternalHBsAg serology and infant testing. Liver International 2018; 38(7) doi: 10.1111/liv.13736
|
| 56 |
Tram T. Tran, Stuart C. Gordon, Scott Fung, Phillip Dinh, Leland Yee, Eduardo Bruno Martins, Maria Buti, Patrick Marcellin, Claire Thorne. Hepatitis B e Antigen Status and Hepatitis B DNA Levels in Women of Childbearing Age with Chronic Hepatitis B Infection Screening for Clinical Trials. PLOS ONE 2015; 10(3) doi: 10.1371/journal.pone.0121632
|
| 57 |
. 2021; doi: 10.70675/46b97ab0zf55dz4723z8de3z1c2d625ea853
|
| 58 |
Pai-Jong Stacy Tsai, Ann Chang, Seiji Yamada, Naoky Tsai, Marguerite Lisa Bartholomew. Use of Tenofovir Disoproxil Fumarate in Highly Viremic, Hepatitis B Mono-Infected Pregnant Women. Digestive Diseases and Sciences 2014; 59(11) doi: 10.1007/s10620-014-3230-3
|
| 59 |
M. H. Hyun, Y.‐S. Lee, J. H. Kim, J. H. Je, Y. J. Yoo, J. E. Yeon, K. S. Byun. Systematic review with meta‐analysis: the efficacy and safety of tenofovir to prevent mother‐to‐child transmission of hepatitis B virus. Alimentary Pharmacology & Therapeutics 2017; 45(12) doi: 10.1111/apt.14068
|
| 60 |
Murat Afyon, Cumhur Artuk. Perinatal Hepatitis B Virüs Bulaşı. Arşiv Kaynak Tarama Dergisi 2016; 25(22109) doi: 10.17827/aktd.237672
|
| 61 |
Christian Ngounouh Taheu, Philippe Salomon Nguwoh, Ahie Demtaley, Patrice Zanga Olinga, Joseph Fokam. Seroprevalence of Hepatitis B Virus using HBV-5 Rapid Panel Test and Associated Factors amongst Pregnant Women Attending Antenatal Care in Garoua, North-Cameroon. European Journal of Medical and Health Sciences 2022; 4(1) doi: 10.24018/ejmed.2022.4.1.1147
|
| 62 |
Dost Sarpel, Tatyana Kushner, Danielle Carter, Tsipora Huisman, Sophia Chiu, Douglas Dieterich. Mother-to-child Transmission of Hepatitis B and C Virus: Review of the Epidemiology and Current Treatment Options. Future Virology 2018; 13(1) doi: 10.2217/fvl-2017-0069
|
| 63 |
M. D. Akhmedova, Sh. A. Tashpulatova, G. A. Ikhtiyarova, M. T. Karimova. Chronic viral hepatitis B and D in pregnant women: course and outcomes (review). Journal Infectology 2021; 13(2) doi: 10.22625/2072-6732-2021-13-2-29-37
|
| 64 |
Lauren M. Bleich, Eugene S. Swenson. Prevention of Neonatal Hepatitis B Virus Transmission. Journal of Clinical Gastroenterology 2014; 48(9) doi: 10.1097/MCG.0000000000000115
|
| 65 |
Malgorzata Pawlowska, Anna Pniewska, Malgorzata Pilarczyk, Dorota Kozielewicz, Krzysztof Domagalski. Prophylaxis of vertical HBV infection. Expert Opinion on Drug Safety 2016; 15(10) doi: 10.1080/14740338.2016.1211106
|
| 66 |
Hongsen Chen, Jie Xu, Wenbin Liu, Xi Chen, Ping Li, Guangwen Cao. The epidemiology, etiology, and future prophylactic options for cancers in Mainland China. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1579378
|
| 67 |
L. Wang, A. P. Kourtis, S. Ellington, J. Legardy-Williams, M. Bulterys. Safety of Tenofovir During Pregnancy for the Mother and Fetus: A Systematic Review. Clinical Infectious Diseases 2013; 57(12) doi: 10.1093/cid/cit601
|
| 68 |
Suda Tekin Koruk, Ayse Batirel, Sukran Kose, Sila Cetin Akhan, Bilgehan Aygen, Necla Tulek, Çigdem Hatipoglu, Cemal Bulut, Orhan Yıldız, Cahide Sacligil, Fatma Sirmatel, Elif Altunok. Evaluation of hepatitis B virus transmission and antiviral therapy among hepatitis B surface antigen‐positive pregnant women. Journal of Obstetrics and Gynaecology Research 2015; 41(12) doi: 10.1111/jog.12821
|
| 69 |
Quanxin Wu, Hongfei Huang, Xiaowen Sun, Meimin Pan, Yun He, Shun Tan, Yi Zeng, Li Li, Guohong Deng, Zehui Yan, Dengming He, Junnan Li, Yuming Wang. Telbivudine Prevents Vertical Transmission of Hepatitis B Virus From Women With High Viral Loads: A Prospective Long-Term Study. Clinical Gastroenterology and Hepatology 2015; 13(6) doi: 10.1016/j.cgh.2014.08.043
|
| 70 |
Norah A. Terrault, Natalie H. Bzowej, Kyong‐Mi Chang, Jessica P. Hwang, Maureen M. Jonas, M. Hassan Murad. AASLD guidelines for treatment of chronic hepatitis B. Hepatology 2016; 63(1) doi: 10.1002/hep.28156
|
| 71 |
Li-fen Han, Jian-ming Zheng, Li-qing Zheng, Hai-bing Gao, Li-xia Chen, Qing-ling Xu, Yi-hong Chai, Xin Zhang, Chen Pan, Lv-feng Yao. Telbivudine can safely reduce mother-to-child transmission in chronic hepatitis B women after 12 weeks of gestation. BMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-4250-6
|
| 72 |
Jinlin Hou, Guiqiang Wang, Fusheng Wang, Jun Cheng, Hong Ren, Hui Zhuang, Jian Sun, Lanjuan Li, Jie Li, Qinghua Meng, Jingmin Zhao, Zhongping Duan, Jidong Jia, Hong Tang, Jifang Sheng, Jie Peng, Fengmin Lu, Qing Xie, Lai Wei. Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update). Journal of Clinical and Translational Hepatology 2017; 5(4) doi: 10.14218/JCTH.2016.00019
|
| 73 |
Tram T. Tran. Hepatitis B virus in pregnancy. Clinical Liver Disease 2013; 2(1) doi: 10.1002/cld.159
|
| 74 |
Wenjun Wang, Jingjing Wang, Shuangsuo Dang, Guihua Zhuang. Cost-effectiveness of antiviral therapy during late pregnancy to prevent perinatal transmission of hepatitis B virus. PeerJ 2016; 4 doi: 10.7717/peerj.1709
|
| 75 |
Wei Wu, Yu Zhu, Chenbo Yu, Shigui Yang, Bing Ruan, Yu Chen, Lanjuan Li. Clinical features of treatment-naive patients with hepatitis B virus infection. Medicine 2017; 96(16) doi: 10.1097/MD.0000000000006660
|
| 76 |
Jordan Feld, Harry L.A. Janssen, Zaigham Abbas, Andre Elewaut, Peter Ferenci, Vasily Isakov, Aamir G. Khan, Seng Gee Lim, Stephen A. Locarnini, Suzane K. Ono, Jose Sollano, Catherine W. Spearman, Chau-Ting Yeh, Man Fung Yuen, Anton LeMair. World Gastroenterology Organisation Global Guideline Hepatitis B. Journal of Clinical Gastroenterology 2016; 50(9) doi: 10.1097/MCG.0000000000000647
|
| 77 |
Michelle L. Giles, Ruth Grace, Amy Tai, Katarzyna Michalak, Susan P. Walker. Prevention of mother‐to‐child transmission of hepatitis B virus (HBV) during pregnancy and the puerperium: Current standards of care. Australian and New Zealand Journal of Obstetrics and Gynaecology 2013; 53(3) doi: 10.1111/ajo.12061
|
| 78 |
Analysis of certain clinical characteristics of hepatitis delta virus (HDV) patients. International Journal of Biosciences (IJB) 2019; doi: 10.12692/ijb/15.4.387-394
|
| 79 |
Zhao Zhang, Chao Chen, Zhe Li, Ying-Hua Wu, Xiao-Min Xiao. Individualized management of pregnant women with high hepatitis B virus DNA levels. World Journal of Gastroenterology 2014; 20(34): 12056-12061 doi: 10.3748/wjg.v20.i34.12056
|
| 80 |
Shashank Shekhar, Gaurav Diddi. Liver disease in pregnancy. Taiwanese Journal of Obstetrics and Gynecology 2015; 54(5) doi: 10.1016/j.tjog.2015.01.004
|
| 81 |
Wenyu Kang, Qiongfen Li, Liping Shen, Lifen Zhang, Ziying Tian, Lin Xu, Feng Qiu, Feng Wang. Risk factors related to the failure of prevention of hepatitis B virus Mother-to-Child transmission in Yunnan, China. Vaccine 2017; 35(4) doi: 10.1016/j.vaccine.2016.12.016
|
| 82 |
Tram T. Tran. Hepatitis B in Pregnancy. Current Hepatitis Reports 2013; 12(1) doi: 10.1007/s11901-012-0154-2
|
| 83 |
Haruki Komatsu, Ayano Inui. Hepatitis B virus infection in children. Expert Review of Anti-infective Therapy 2015; 13(4) doi: 10.1586/14787210.2015.1019867
|
| 84 |
Lin Fan, Kwame Owusu-Edusei, Sarah F. Schillie, Trudy V. Murphy. Cost-Effectiveness of Testing Hepatitis B–Positive Pregnant Women for Hepatitis B e Antigen or Viral Load. Obstetrics & Gynecology 2014; 123(5) doi: 10.1097/AOG.0000000000000124
|
| 85 |
Xuan Huang, Jing Tang. Virus infection and direct-acting antivirals in pregnancy. Clinical and Experimental Obstetrics & Gynecology 2022; 49(4) doi: 10.31083/j.ceog4904089
|
| 86 |
Filomena Morisco, Raffaele Bruno, Elisabetta Bugianesi, Patrizia Burra, Vincenza Calvaruso, Alice Cannoni, Nicola Caporaso, Gian Paolo Caviglia, Alessia Ciancio, Silvia Fargion, Alessandro Federico, Annarosa Floreani, Giovanni Battista Gaeta, Maria Guarino, Pietro Invernizzi, Anna Licata, Carmela Loguercio, Giuseppe Mazzella, Felice Petraglia, Massimo Primignani, Kryssia Rodriguez-Castro, Antonina Smedile, Luca Valenti, Ester Vanni, Silvia Vannuccini, Chiara Voltolini, Erica Villa. AISF position paper on liver disease and pregnancy. Digestive and Liver Disease 2016; 48(2) doi: 10.1016/j.dld.2015.11.004
|
| 87 |
Robert S. Brown, Brian J. McMahon, Anna S.F. Lok, John B. Wong, Ahmed T. Ahmed, Mohamed A. Mouchli, Zhen Wang, Larry J. Prokop, Mohammad Hassan Murad, Khaled Mohammed. Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta‐analysis. Hepatology 2016; 63(1) doi: 10.1002/hep.28302
|
| 88 |
Yoon Seok Lee, Soo Min Bang, Young-Sun Lee. Benefits and Risks of Antiviral Treatment during Pregnancy in Patients with Chronic Hepatitis B. Journal of Clinical Medicine 2021; 10(11) doi: 10.3390/jcm10112320
|
| 89 |
Angela M. Diaz, Errol R. Norwitz. Treatment of Viral Infections During Pregnancy. Clinics in Perinatology 2026; 53(3) doi: 10.1016/j.clp.2026.04.007
|
| 90 |
H. Dilek DOĞAN, Çisem BAŞTARCAN. HEPATİT B PREVALANSINDAKİ GİZEM: HEPATİT B ve GEBELİK. Izmir Democracy University Health Sciences Journal 2021; 4(1) doi: 10.52538/iduhes.923716
|
| 91 |
Javier Arístegui Fernández, Javier Díez-Domingo, Josep Marés Bermúdez, Federico Martinón Torres. Vacunación frente a la hepatitisB. Impacto de los programas de vacunación tras 20años de su utilización en España. ¿Es tiempo de cambios?. Enfermedades Infecciosas y Microbiología Clínica 2015; 33(2) doi: 10.1016/j.eimc.2014.12.010
|
| 92 |
Min-Hui Liu, Yun-Jian Sheng, Jun-Ying Liu, Huai-Dong Hu, Qiong-Fang Zhang, Hong Ren. Efficacy of telbivudine on interruption of hepatitis B virus vertical transmission: a meta-analysis. Annals of Saudi Medicine 2013; 33(2) doi: 10.5144/0256-4947.2013.169
|
| 93 |
W. Yi, M.‐H. Li, Y. Xie, J. Wu, Y.‐H. Hu, D. Zhang, Y. Zhang, W.‐H. Cao. Prospective cohort study on the efficacy and safety of telbivudine used throughout pregnancy in blocking mother‐to‐child transmission of hepatitis B virus. Journal of Viral Hepatitis 2017; 24(S1) doi: 10.1111/jvh.12788
|
| 94 |
Eliana Castillo, Kellie Murphy, Julie van Schalkwyk. N° 342-L'hépatite B et la grossesse. Journal of Obstetrics and Gynaecology Canada 2017; 39(3) doi: 10.1016/j.jogc.2017.01.018
|
| 95 |
B. Biot, N. Laverdure, F. Lacaille, A. Lachaux. Échec de la séroprophylaxie contre le virus de l’hépatite B. Analyse de la littérature et mise au point à partir d’une série de 11 cas de contamination périnatale. Archives de Pédiatrie 2017; 24(2) doi: 10.1016/j.arcped.2016.11.009
|
| 96 |
Mauro Viganò, Massimo Puoti, Pietro Lampertico. Hepatitis B Virus in Human Diseases. Molecular and Translational Medicine 2016; doi: 10.1007/978-3-319-22330-8_16
|
| 97 |
J. Howell, M. Lemoine, M. Thursz. Prevention of materno‐foetal transmission of hepatitis B in sub‐Saharan Africa: the evidence, current practice and future challenges. Journal of Viral Hepatitis 2014; 21(6) doi: 10.1111/jvh.12263
|
| 98 |
Frank Wong, Rohit Pai, Julie Van Schalkwyk, Eric M. Yoshida. Hepatitis B in pregnancy: a concise review of neonatal vertical transmission and antiviral prophylaxis. Annals of Hepatology 2014; 13(2) doi: 10.1016/S1665-2681(19)30881-6
|
| 99 |
Jessica Howell, Caroline Van Gemert, Maud Lemoine, Mark Thursz, Margaret Hellard. An overview of hepatitis B prevalence, prevention, and management in the Pacific Islands and Territories. Journal of Gastroenterology and Hepatology 2014; 29(11) doi: 10.1111/jgh.12684
|
| 100 |
. 2021; doi: 10.70675/161e98a4z95c9z4590zb71bz27df082e9476
|
| 101 |
Yali Ren, Yiyang Guo, Li Feng, Tongyang Li, Yukai Du. Controversy and Strategies Exploration in Blocking Mother-to-Child Transmission of Hepatitis B. International Reviews of Immunology 2016; 35(3) doi: 10.3109/08830185.2015.1096934
|
| 102 |
S. K. Sarin, M. Kumar, G. K. Lau, Z. Abbas, H. L. Y. Chan, C. J. Chen, D. S. Chen, H. L. Chen, P. J. Chen, R. N. Chien, A. K. Dokmeci, Ed Gane, J. L. Hou, W. Jafri, J. Jia, J. H. Kim, C. L. Lai, H. C. Lee, S. G. Lim, C. J. Liu, S. Locarnini, M. Al Mahtab, R. Mohamed, M. Omata, J. Park, T. Piratvisuth, B. C. Sharma, J. Sollano, F. S. Wang, L. Wei, M. F. Yuen, S. S. Zheng, J. H. Kao. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatology International 2016; 10(1) doi: 10.1007/s12072-015-9675-4
|
| 103 |
V. Jackson, W. Ferguson, T. B. Kelleher, M. Lawless, M. Eogan, U. Nusgen, S. Coughlan, J. Connell, J. S. Lambert. Lamivudine treatment and outcome in pregnant women with high hepatitis B viral loads. European Journal of Clinical Microbiology & Infectious Diseases 2015; 34(3) doi: 10.1007/s10096-014-2270-0
|
| 104 |
|
| 105 |
Kumar Visvanathan, Geoff Dusheiko, Michelle Giles, May-Ling Wong, Nghi Phung, Susan Walker, Suong Le, Seng Gee Lim, Ed Gane, Meng Ngu, Winita Hardikar, Ben Cowie, Scott Bowden, Simone Strasser, Miriam Levy, Joe Sasaduesz. Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: position paper produced by Australian, UK and New Zealand key opinion leaders. Gut 2016; 65(2) doi: 10.1136/gutjnl-2015-310317
|
| 106 |
C Wendy Spearman, Mary Afihene, Reidwaan Ally, Betty Apica, Yaw Awuku, Lina Cunha, Geoffrey Dusheiko, Neliswa Gogela, Chris Kassianides, Michael Kew, Philip Lam, Olufunmilayo Lesi, Marie-Jeanne Lohouès-Kouacou, Papa Saliou Mbaye, Emmanuel Musabeyezu, Betty Musau, Olusegun Ojo, John Rwegasha, Barbara Scholz, Abate B Shewaye, Christian Tzeuton, Mark W Sonderup. Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets. The Lancet Gastroenterology & Hepatology 2017; 2(12) doi: 10.1016/S2468-1253(17)30295-9
|
| 107 |
Calvin Q Pan, Lin Zhu, Andy S Yu, Yuchan Zhao, Bo Zhu, Erhei Dai. Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Preventing Vertical Transmission in Chronic Hepatitis B Mothers: A Systematic Review and Meta-Analysis. Clinical Infectious Diseases 2024; 79(4) doi: 10.1093/cid/ciae288
|
| 108 |
Erica J. Hardy, Silvia Degli Esposti, Judy Nee. Medical Management of the Pregnant Patient. 2015; doi: 10.1007/978-1-4614-1244-1_9
|
| 109 |
Eliana Castillo, Kellie Murphy, Julie van Schalkwyk. No. 342-Hepatitis B and Pregnancy. Journal of Obstetrics and Gynaecology Canada 2017; 39(3) doi: 10.1016/j.jogc.2016.11.001
|
| 110 |
Alexandra Benachi, Dominique Luton, Laurent Mandelbrot, Olivier Picone. Pathologies Maternelles et Grossesse. 2022; doi: 10.1016/B978-2-294-77351-8.00005-5
|
| 111 |
|